Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.

Chronic Hepatitis B Functional cure Hepatitis B virus Qualitative research Self-stigma Social impact

Journal

BMC public health

ISSN: 1471-2458

Titre abrégé: BMC Public Health

Pays: England

ID NLM: 100968562

Informations de publication

Date de publication:
26 Feb 2024

Historique:

received: 26 07 2022

accepted: 19 11 2023

medline: 27 2 2024

pubmed: 27 2 2024

entrez: 26 2 2024

Statut: epublish

Résumé

People with chronic hepatitis B (CHB) commonly experience social and self-stigma. This study sought to understand the impacts of CHB-related stigma and a functional cure on stigma. Adults with CHB with a wide range of age and education were recruited from 5 countries and participated in 90-minute qualitative, semi-structured interviews to explore concepts related to CHB-associated stigma and its impact. Participants answered open-ended concept-elicitation questions regarding their experience of social and self-stigma, and the potential impact of reduced CHB-related stigma. Sixty-three participants aged 25 to 71 years (15 from the United States and 12 each from China, Germany, Italy, and Japan) reported emotional, lifestyle, and social impacts of living with CHB, including prejudice, marginalization, and negative relationship and work experiences. Self-stigma led to low self-esteem, concealment of CHB status, and social withdrawal. Most participants stated a functional cure for hepatitis B would reduce self-stigma. CHB-related social and self-stigma are widely prevalent and affect many aspects of life. A functional cure for hepatitis B may reduce social and self-stigma and substantially improve the health-related quality of life of people with CHB. Incorporating stigma into guidelines along with infectivity considerations may broaden the patient groups who should receive treatment.

Sections du résumé

BACKGROUND BACKGROUND

People with chronic hepatitis B (CHB) commonly experience social and self-stigma. This study sought to understand the impacts of CHB-related stigma and a functional cure on stigma.

METHODS METHODS

Adults with CHB with a wide range of age and education were recruited from 5 countries and participated in 90-minute qualitative, semi-structured interviews to explore concepts related to CHB-associated stigma and its impact. Participants answered open-ended concept-elicitation questions regarding their experience of social and self-stigma, and the potential impact of reduced CHB-related stigma.

RESULTS RESULTS

Sixty-three participants aged 25 to 71 years (15 from the United States and 12 each from China, Germany, Italy, and Japan) reported emotional, lifestyle, and social impacts of living with CHB, including prejudice, marginalization, and negative relationship and work experiences. Self-stigma led to low self-esteem, concealment of CHB status, and social withdrawal. Most participants stated a functional cure for hepatitis B would reduce self-stigma.

CONCLUSIONS CONCLUSIONS

CHB-related social and self-stigma are widely prevalent and affect many aspects of life. A functional cure for hepatitis B may reduce social and self-stigma and substantially improve the health-related quality of life of people with CHB. Incorporating stigma into guidelines along with infectivity considerations may broaden the patient groups who should receive treatment.

Identifiants

DOI: 10.1186/s12889-023-17263-6 PMID: 38408941

pubmed: 38408941

doi: 10.1186/s12889-023-17263-6

pii: 10.1186/s12889-023-17263-6

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

611

Informations de copyright

Références

World Health Organization, Hepatitis B. 2021. https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b . Accessed 20 Jul 2022.

The Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus Infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403.

doi: 10.1016/S2468-1253(18)30056-6

Coppola N, Alessio L, Pisaturo M, Macera M, Sagnelli C, Zampino R, et al. Hepatitis B virus Infection in immigrant populations. World J Hepatol. 2015;7(30):2955–61.

doi: 10.4254/wjh.v7.i30.2955 pubmed: 26730274 pmcid: 4691698

Smith-Palmer J, Cerri K, Sbarigia U, Chan EKH, Pollock RF, Valentine WJ, et al. Impact of stigma on people living with chronic hepatitis B. Patient Relat Outcome Meas. 2020;11:95–107.

doi: 10.2147/PROM.S226936 pubmed: 32214859 pmcid: 7082540

Moraras K, Block J, Shiroma N, Cannizzo A, Cohen C. Protecting the rights of health care students living with hepatitis B under the americans with disabilities act. Public Health Rep. 2020;135(1 Suppl):13S–18S.

doi: 10.1177/0033354920921252 pubmed: 32735187 pmcid: 7407047

Mokaya J, McNaughton AL, Burbridge L, Maponga T, O’Hara G, Andersson M, et al. A blind spot? Confronting the stigma of hepatitis B virus (HBV) Infection - a systematic review. Wellcome Open Res. 2018;3:29.

doi: 10.12688/wellcomeopenres.14273.1 pubmed: 30483598 pmcid: 6234740

McCulloch K, Romero N, MacLachlan J, Allard N, Cowie B. Modeling progress toward elimination of hepatitis B in Australia. Hepatology. 2020;71(4):1170–81.

doi: 10.1002/hep.30899 pubmed: 31419332

Wallace J, McNally S, Richmond J, Hajarizadeh B, Pitts M. Managing chronic Hepatitis B: a qualitative study exploring the perspectives of people living with chronic hepatitis B in Australia. BMC Res Notes. 2011;4: 45.

doi: 10.1186/1756-0500-4-45 pubmed: 21371332 pmcid: 3060129

Corrigan PW, Rao D. On the self-stigma of mental illness: stages, disclosure, and strategies for change. Can J Psychiatry. 2012;57(8):464–9.

doi: 10.1177/070674371205700804 pubmed: 22854028

Hepatitis B Foundation. The voice of the patient: living with chronic hepatitis B. Report of an externally-led patient-focused drug development meeting. 2020. https://www.hepb.org/assets/Uploads/ExPFDD-Report-HBF-10-1-2020.pdf . Accessed 20 Jul 2022.

Jin D, Treloar C, Brener L. Hepatitis B virus related stigma among Chinese living in mainland China: a scoping review. Psychol Health Med. 2022;27(8):1760–73.

Ainsworth C. Destigmatizing hepatitis B. Nature. 2022;603(7903):54–6.

doi: 10.1038/d41586-022-00816-x

Huang J, Guan ML, Balch J, Wu E, Rao H, Lin A, et al. Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China. Liver Int. 2016;36(11):1595–603.

doi: 10.1111/liv.13168 pubmed: 27206379

Freeland C, Farrell S, Kumar P, Kamischke M, Jackson M, Bodor S, et al. Common concerns, barriers to care, and the lived experience of individuals with hepatitis B: a qualitative study. BMC Public Health. 2021;21(1):1004.

doi: 10.1186/s12889-021-11093-0 pubmed: 34044808 pmcid: 8161662

Han B, Yuan Q, Shi Y, Wei L, Hou J, Shang J, et al. The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China. PLoS One. 2018;13(4):e0195455.

doi: 10.1371/journal.pone.0195455 pubmed: 29649232 pmcid: 5896961

Wallace J, Pitts M, Liu C, Lin V, Hajarizadeh B, Richmond J, et al. More than a virus: a qualitative study of the social implications of hepatitis B infection in China. Int J Equity Health. 2017;16(1):137.

doi: 10.1186/s12939-017-0637-4 pubmed: 28764768 pmcid: 5540563

Tu T, Block JM, Wang S, Cohen C, Douglas MW. The lived experience of chronic hepatitis B: a broader view of its impacts and why we need a cure. Viruses. 2020;12(5):515.

doi: 10.3390/v12050515 pubmed: 32392763 pmcid: 7290920

Vogel DL, Bitman RL, Hammer JH, Wade NG. Is stigma internalized? The longitudinal impact of public stigma on self-stigma. J Couns Psychol. 2013;60(2):311–6.

doi: 10.1037/a0031889 pubmed: 23421775

Corrigan PW, Kerr A, Knudsen L. The stigma of mental illness: explanatory models and methods for change. Appl Prev Psychol. 2005;11(3):179–90.

doi: 10.1016/j.appsy.2005.07.001

Valizadeh L, Zamanzadeh V, Bayani M, Zabihi A. The social stigma experience in patients with hepatitis B infection: a qualitative study. Gastroenterol Nurs. 2017;40(2):143–50.

doi: 10.1097/SGA.0000000000000223 pubmed: 28362662

Le TV, Vu TTM, Mai HT, Nguyen LH, Truong NT, Hoang CL, et al. Social determinants of stigma and discrimination in Vietnamese patients with chronic hepatitis B. Int J Environ Res Public Health. 2019;16(3):398.

doi: 10.3390/ijerph16030398 pubmed: 30708943 pmcid: 6388214

Liu K. Hepatitis B infection in China: the stigma behind the stigmata. Liver Int. 2016;36(11):1582–4.

doi: 10.1111/liv.13189 pubmed: 27744655

Li D, Tang T, Patterson M, Ho M, Heathcote J, Shah H. The impact of hepatitis B knowledge and stigma on screening in Canadian Chinese persons. Can J Gastroenterol. 2012;26(9):597–602.

doi: 10.1155/2012/705094 pubmed: 22993729 pmcid: 3441165

Wallace J, McNally S, Richmond J, Hajarizadeh B, Pitts M. Challenges to the effective delivery of health care to people with chronic hepatitis B in Australia. Sex Health. 2012;9(2):131–7.

doi: 10.1071/SH10137 pubmed: 22498156

World Hepatitis Alliance. Holding governments accountable. World Hepatitis Alliance Civil Society Survey: global findings report. 2017. https://www.worldhepatitisalliance.org/wp-content/uploads/2017/10/holding_governments_accountable_-_civil_society_survey_report.pdf . Accessed 20 Jul 2022.

Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1–98.

doi: 10.1007/s12072-015-9675-4 pubmed: 26563120

Lok AS, Zoulim F, Dusheiko G, Ghany MG. Hepatitis B cure: from discovery to regulatory approval. Hepatology. 2017;66(4):1296–313.

doi: 10.1002/hep.29323 pubmed: 28762522

US Food & Drug Administration. Plan for issuance of patient-focused drug development guidance under 21st Century Cures Act Title III Section 3002. 2017. https://www.fda.gov/files/about%20fda/published/Plan-for-Issuance-of-Patient%E2%80%90Focused-Drug-Development-Guidance.pdf . Accessed 20 Jul 2022.

Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, et al. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research practices Task Force report: part 2—assessing respondent understanding. Value Health. 2011;14(8):978–88.

doi: 10.1016/j.jval.2011.06.013 pubmed: 22152166

Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77–101.

doi: 10.1191/1478088706qp063oa

Guest G, MacQueen KM, Namey EE. Applied thematic analysis. Thousand Oaks: Sage; 2012.

doi: 10.4135/9781483384436

Fusch PI, Ness LR. Are we there yet? Data saturation in qualitative research. Qual Rep. 2015;20(9):1408–16.

Choi HSJ, Tonthat A, Janssen HLA, Terrault NA. Aiming for functional cure with established and novel therapies for chronic hepatitis B. Hepatol Commun. 2022;6(5):935–49.

doi: 10.1002/hep4.1875 pubmed: 34894108

Wallace J, Pitts M, Liu C, Lin V, Wei L, Hajarizadeh B, et al. Needs assessment of people with viral hepatitis – China. 2015. https://www.researchgate.net/profile/Jack-Wallace-3/publication/280721610_Needs_assessment_of_people_with_viral_hepatitis_China/links/55c2bc5008aebc967defe1d6/Needs-assessment-of-people-with-viral-hepatitis-China.pdf . Accessed 20 Jul 2022.

Wallace J, Richmond J, Allard N, Howell J, Adamson E, Xiao Y, et al. Facilitating hepatitis B clinical management in general practice: a qualitative investigation. Aust J Gen Pract. 2020;49(9):599–604.

doi: 10.31128/AJGP-02-20-5225 pubmed: 32864675

Ishimaru T, Wada K, Arphorn S, Smith DR. Barriers to the acceptance of work colleagues infected with hepatitis B and hepatitis C in Japan. J Occup Health. 2016;58(3):269–75.

doi: 10.1539/joh.15-0288-OA pubmed: 27108645 pmcid: 5356951

Eguchi H, Wada K. Knowledge of HBV and HCV and individuals’ attitudes toward HBV- and HCV-infected colleagues: a national cross-sectional study among a working population in Japan. PLoS One. 2013;8(9):e76921.

doi: 10.1371/journal.pone.0076921 pubmed: 24086765 pmcid: 3784392

Freeland C, Racho R, Kamischke M, Moraras K, Wang E, Cohen C. Cure everyone and vaccinate the rest: the patient perspective on future hepatitis B treatment. J Viral Hepat. 2021;28(11):1539–44.

doi: 10.1111/jvh.13592 pubmed: 34363715